Multivariate Analysis of Integrated and Full-Resolution ¹H-NMR Spectral Data from Complex Pharmaceutical Preparations: St. John’s Wort

Abstract

Commercial herbal preparations are typically very complex mixtures and the relationship between content of various constituents and pharmacological action of the formulation is usually unclear. Such formulations are nevertheless standardized using a single marker constituent or a group of closely related constituents, which provides no information about other abundant constituents present in the extract. In this study, principal component analysis of 600 MHz ¹H-NMR spectra of extracts of commercial formulations of St. John’s wort (Hypericum perforatum), acquired in methanol-d ₄ and DMSO-d ₆, was shown to be able to discriminate between various preparations according to their global composition, including differentiation between various batches from the same supplier, while no clustering into classes of tablets and capsules was observed. This suggests that the plant extract variability rather than the manufacturing process accounts for the data clustering. Major variations in the content of flavonoids, recently linked to the antidepressant activity of St. John’s wort extracts, were detected. Use of two NMR solvents provided complementary data sets, allowing assessment of various aspects of sample composition from separate PCA models. Both integrated (about 200 variables) and full-resolution NMR data (about 30 000 variables) have been used. The latter approach, applied for the first time in analysis of a herbal preparation, provided via loading plots more precise information about constituents responsible for data clustering, and may be generally preferable for PCA analysis of NMR data of plant extracts and herbal medicines.

St. John’s wort - NMR spectroscopy - pattern recognition - principal component analysis - data reduction - quality control

References

• 1 European Pharmacopoeia. 5th edn Strasbourg; Council of Europe 2005: p 2485-6
• 2 Bauer R. Quality criteria and standardization of phytopharmaceuticals: can acceptable drug standards be achieved?.  Drug Inf J. 1998;  32 101-10
• 3 Barnes J, Anderson L A, Phillipson J D. St John’s wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.  J Pharm Pharmacol. 2001;  53 583-600
• 4 Butterweck V. Mechanism of action of St John’s wort in depression - what is known?.  CNS Drugs. 2003;  17 539-62
• 5 Szegedi A, Kohnen R, Dienel A, Kieser M. Acute treatment of moderate to severe depression with Hypericum extract WS 5570 (St John’s wort): randomised controlled double blind non-inferiority trial versus paroxetine.  Br Med J. 2005;  330 503-6
• 6 Lindon J C, Holmes E, Nicholson J K. Metabonomics: systems biology in pharmaceutical research and development.  Curr Opin Mol Ther. 2004;  6 265-72
• 7 Lindon J C, Holmes E, Bollard M E, Stanley E G, Nicholson J K. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.  Biomarkers. 2004;  9 1-31
• 8 Lindon J C, Holmes E, Nicholson J K. Pattern recognition methods and applications in biomedical magnetic resonance.  Prog Nucl Magn Reson Spectrom. 2001;  39 1-40
• 9 Choi H K, Choi Y H, Verberne M, Lefeber A WM, Erkelens C, Verpoorte R. Metabolic fingerprinting of wild type and transgenic tobacco plants by ¹H NMR and multivariate analysis technique.  Phytochemistry. 2004;  65 857-64
• 10 Choi Y H, Kim H K, Hazekamp A, Erkelens C, Lefeber A WM, Verpoorte R. Metabolomic differentiation of Cannabis sativa cultivars using ¹H NMR spectroscopy and principal component analysis.  J Nat Prod. 2004;  67 953-7
• 11 Frederich M, Choi Y H, Angenot L, Harnischfeger G, Lefeber A WM, Verpoorte R. Metabolomic analysis of Strychnos nux-vomica, Strychnos icaja and Strychnos ignatii extracts by ¹H nuclear magnetic resonance spectrometry and multivariate analysis techniques.  Phytochemistry. 2004;  65 1993-2001
• 12 Wang Y L, Tang H R, Nicholson J K, Hylands P J, Sampson J, Whitcombe I. et al . Metabolomic strategy for the classification and quality control of phytomedicine: a case study of chamomile flower (Matricaria recutita L.)  Planta Med. 2004;  70 250-5
• 13 Roos G, Roseler C, Buter K B, Simmen U. Classification and correlation of St. John’s wort extracts by nuclear magnetic resonance spectroscopy, multivariate data analysis and pharmacological activity.  Planta Med. 2004;  70 771-7
• 14 Kim H K, Choi Y H, Erkelens C, Lefeber A WM, Verpoorte R. Metabolic fingerprinting of Ephedra species using ¹H-NMR spectroscopy and principal component analysis.  Chem Pharm Bull. 2005;  53 105-9
• 15 Bailey N J, Sampson J, Hylands P J, Nicholson J K, Holmes E. Multi-component metabolic classification of commercial feverfew preparations via high-field ¹H-NMR spectroscopy and chemometrics.  Planta Med. 2002;  68 734-8
• 16 Bilia A R, Bergonzi M C, Mazzi G, Vincieri F F. Analysis of plant complex matrices by use of nuclear magnetic resonance spectroscopy: St. John’s wort extract.  J Agric Food Chem. 2001;  49 2115-24
• 17 Krishnan P, Kruger N J, Ratcliffe R G. Metabolite fingerprinting and profiling in plants using NMR.  J Exp Bot. 2005;  56 255-65
• 18 Xu L, Wei C E, Zhao M B, Wang J N, Tu P F, Liu J X. Experimental study of the total flavonoids in Hypericum perforatum on depression.  Zhongguo Zhong Yao Za Zhi. 2005;  30 1184-8
• 19 Butterweck V, Hegger M, Winterhoff H. Flavonoids of St. John’s wort reduce HPA axis function in the rat.  Planta Med. 2004;  70 1008-11
• 20 Noldner M, Schotz K. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test.  Planta Med. 2002;  68 577-80
• 21 Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test.  Planta Med. 2000;  66 3-6